GlassScriptPhysician profile
Rod D Serry
NPI 1912945130
$47,636.37
in general payments reported to CMS, 2019-2025
22 companies · $1,494 in 2025
The $1,494 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,840 · 2020: $677 · 2021: $14K · 2022: $29K · 2023: $625 · 2024: $655 · 2025: $1,494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,774.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $44,901.70 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $501.04 | 2019-2025 | |
| Medtronic Vascular, INC. | $465.72 | 2019-2020 | |
| Shockwave Medical, INC | $399.20 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $260.40 | 2019-2023 | Synergy, Rotapro, Watchman |
| Angiodynamics, INC. | $205.94 | 2024 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $186.80 | 2021 | |
| Endologix LLC | $186.05 | 2025 | Alto Abdominal Stent Graft System |
| Biotronik INC. | $177.03 | 2021-2023 | Amvia Edge, Acticor 7 Vr-T Dx |
| Actelion Pharmaceuticals US, INC. | $53.73 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $48.85 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $37.14 | 2019-2024 | Camzyos |
| Amgen INC. | $36.96 | 2020-2025 | Repatha |
| Abbott Laboratories | $27.22 | 2023 | Rhythmview, Mitraclip |
| Irhythm Technologies, INC. | $24.18 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $22.29 | 2019 | |
| Pfizer INC. | $18.74 | 2023 | |
| Baxter Healthcare | $18.26 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Cvrx, INC. | $17.43 | 2024 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $16.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.91 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rod Serry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.